Alluru Reddi

Prof. Alluru Reddi


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2015 in Cells
Verified
Journal Article
Open access
PDF file
MDMargaret Duffy
Margaret Duffy
SJShashank Jain
Shashank Jain
NHNicholas Harrell
Nicholas Harrell
NKNeil Kothari
Neil Kothari
ARAlluru Reddi
Alluru Reddi
The treatment of edema in patients with nephrotic syndrome is generally managed by dietary sodium restriction and loop diuretics. However, edema does not improve in some patients despite adequate sodium restriction and maximal dose of diuretics. In such patients, combination of albumin and a loop diuretic may improve edema by diuresis and natriuresis. The response to this combination of albumin and a diuretic has not been observed in all studies. The purpose of this review is to discuss the physiology of diuresis and natriuresis of this combination therapy, and provide a brief summary of various studies that have used albumin and a loop diuretic to improve diuretic-resistant edema. Also, the review suggests various reasons for not observing similar results by various investigators.

10 April 2015 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
ARAlluru Reddi
Alluru Reddi
NKNeil Kothari
Neil Kothari
KKKishore Kuppasani
Kishore Kuppasani
NENorman Ende
Norman Ende
Abstract: Stem cell therapy for patients with diabetes is an area of great interest to both scientists and clinicians. Human umbilical cord blood cells (HUCBCs) are being increasingly used as a source of stem cells for cell-based therapy for diabetes because these cells can differentiate into pancreatic islet β-cells. Administration of HUCBCs has been shown to lower blood glucose levels in diabetic animal models. The use of autologous HUCBC transfusion in type 1 diabetic children has not shown any benefit. However, “Stem Cell Educator” therapy has shown promise in long term lowering of blood glucose levels in both type 1 and type 2 diabetic patients. In this review, we will briefly discuss recent advances in HUCBC therapy in the treatment of diabetes and some of its complications.

23 October 2013
Verified
Book Chapter
Closed access
PDF file
ARAlluru Reddi
Alluru Reddi

23 October 2013
Verified
Book Chapter
Closed access
PDF file
ARAlluru Reddi
Alluru Reddi

23 October 2013
Verified
Book Chapter
Closed access
PDF file
ARAlluru Reddi
Alluru Reddi